Skip to main content
PMC home page
Philosophical Transactions of the Royal Society B: Biological Sciences logoLink to Philosophical Transactions of the Royal Society B: Biological Sciences
. 1999 Oct 29;354(1390):1615–1622. doi: 10.1098/rstb.1999.0506

Multiple sclerosis: the disease and its manifestations.

W I McDonald 1, M A Ron 1
PMCID: PMC1692676  PMID: 10603614

Abstract

Multiple sclerosis is an immune-mediated inflammatory demyelinating disease of the central nervous system clinically characterized by relapses and remissions of neurological disturbance. A typical relapse, exemplified by optic neuritis, increases in severity over a week or two and after approximately one month begins to remit. Resolution takes place over the course of two to three months. In the early stages, clinical recovery is virtually complete, though persistent abnormalities of conduction can usually be detected by evoked potential techniques and persistent structural abnormalities can be detected by magnetic resonance imaging (MRI). These techniques, together with cerebrospinal fluid examination for oligoclonal IgG, provide supporting evidence for the diagnosis which, in the absence of a specific test, nevertheless remains primarily clinical. The course of the disease is very variable, but after a number of years neurological deficit begins to accumulate after each relapse. In most patients, the relapsing and remitting phase of the disease is followed by a phase of continuous progression of disability. Cognitive disturbances can be detected in many patients even quite early in the course of the illness. Deficits in attention, memory and executive skills may be prominent and tend to become increasingly prominent as neurological deficit increases, although this is not always the case. There is some correlation between the extent of MRI abnormalities in the cerebral white matter and the severity of cognitive deficit. Depression and anxiety are commonly experienced but are poorly correlated to the lesion load seen on MRI. In contrast, the much rarer psychotic symptoms, euphoria and emotional lability are closely linked to the severity of white matter disease.

Full Text

The Full Text of this article is available as a PDF (370.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amato M. P., Ponziani G., Pracucci G., Bracco L., Siracusa G., Amaducci L. Cognitive impairment in early-onset multiple sclerosis. Pattern, predictors, and impact on everyday life in a 4-year follow-up. Arch Neurol. 1995 Feb;52(2):168–172. doi: 10.1001/archneur.1995.00540260072019. [DOI] [PubMed] [Google Scholar]
  2. Andersson M., Alvarez-Cermeño J., Bernardi G., Cogato I., Fredman P., Frederiksen J., Fredrikson S., Gallo P., Grimaldi L. M., Grønning M. Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report. J Neurol Neurosurg Psychiatry. 1994 Aug;57(8):897–902. doi: 10.1136/jnnp.57.8.897. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Arnett P. A., Rao S. M., Bernardin L., Grafman J., Yetkin F. Z., Lobeck L. Relationship between frontal lobe lesions and Wisconsin Card Sorting Test performance in patients with multiple sclerosis. Neurology. 1994 Mar;44(3 Pt 1):420–425. doi: 10.1212/wnl.44.3_part_1.420. [DOI] [PubMed] [Google Scholar]
  4. Arnold A. C., Pepose J. S., Hepler R. S., Foos R. Y. Retinal periphlebitis and retinitis in multiple sclerosis. I. Pathologic characteristics. Ophthalmology. 1984 Mar;91(3):255–262. doi: 10.1016/s0161-6420(84)34296-8. [DOI] [PubMed] [Google Scholar]
  5. Brønnum-Hansen H., Koch-Henriksen N., Hyllested K. Survival of patients with multiple sclerosis in Denmark: a nationwide, long-term epidemiologic survey. Neurology. 1994 Oct;44(10):1901–1907. doi: 10.1212/wnl.44.10.1901. [DOI] [PubMed] [Google Scholar]
  6. Callanan M. M., Logsdail S. J., Ron M. A., Warrington E. K. Cognitive impairment in patients with clinically isolated lesions of the type seen in multiple sclerosis. A psychometric and MRI study. Brain. 1989 Apr;112(Pt 2):361–374. doi: 10.1093/brain/112.2.361. [DOI] [PubMed] [Google Scholar]
  7. Comi G., Filippi M., Martinelli V., Campi A., Rodegher M., Alberoni M., Sirabian G., Canal N. Brain MRI correlates of cognitive impairment in primary and secondary progressive multiple sclerosis. J Neurol Sci. 1995 Oct;132(2):222–227. doi: 10.1016/0022-510x(95)00168-2. [DOI] [PubMed] [Google Scholar]
  8. Cowan J. M., Rothwell J. C., Dick J. P., Thompson P. D., Day B. L., Marsden C. D. Abnormalities in central motor pathway conduction in multiple sclerosis. Lancet. 1984 Aug 11;2(8398):304–307. doi: 10.1016/s0140-6736(84)92683-7. [DOI] [PubMed] [Google Scholar]
  9. Fassbender K., Schmidt R., Mössner R., Kischka U., Kühnen J., Schwartz A., Hennerici M. Mood disorders and dysfunction of the hypothalamic-pituitary-adrenal axis in multiple sclerosis: association with cerebral inflammation. Arch Neurol. 1998 Jan;55(1):66–72. doi: 10.1001/archneur.55.1.66. [DOI] [PubMed] [Google Scholar]
  10. Feinstein A., Feinstein K., Gray T., O'Connor P. Prevalence and neurobehavioral correlates of pathological laughing and crying in multiple sclerosis. Arch Neurol. 1997 Sep;54(9):1116–1121. doi: 10.1001/archneur.1997.00550210050012. [DOI] [PubMed] [Google Scholar]
  11. Feinstein A., Kartsounis L. D., Miller D. H., Youl B. D., Ron M. A. Clinically isolated lesions of the type seen in multiple sclerosis: a cognitive, psychiatric, and MRI follow up study. J Neurol Neurosurg Psychiatry. 1992 Oct;55(10):869–876. doi: 10.1136/jnnp.55.10.869. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Feinstein A., Ron M., Thompson A. A serial study of psychometric and magnetic resonance imaging changes in multiple sclerosis. Brain. 1993 Jun;116(Pt 3):569–602. doi: 10.1093/brain/116.3.569. [DOI] [PubMed] [Google Scholar]
  13. Feinstein A., du Boulay G., Ron M. A. Psychotic illness in multiple sclerosis. A clinical and magnetic resonance imaging study. Br J Psychiatry. 1992 Nov;161:680–685. doi: 10.1192/bjp.161.5.680. [DOI] [PubMed] [Google Scholar]
  14. Fog T. The topography of plaques in multiple sclerosis with special reference to cerebral plaques. Acta Neurol Scand Suppl. 1965;15:1–161. [PubMed] [Google Scholar]
  15. Fontaine B., Seilhean D., Tourbah A., Daumas-Duport C., Duyckaerts C., Benoit N., Devaux B., Hauw J. J., Rancurel G., Lyon-Caen O. Dementia in two histologically confirmed cases of multiple sclerosis: one case with isolated dementia and one case associated with psychiatric symptoms. J Neurol Neurosurg Psychiatry. 1994 Mar;57(3):353–359. doi: 10.1136/jnnp.57.3.353. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Foong J., Rozewicz L., Quaghebeur G., Davie C. A., Kartsounis L. D., Thompson A. J., Miller D. H., Ron M. A. Executive function in multiple sclerosis. The role of frontal lobe pathology. Brain. 1997 Jan;120(Pt 1):15–26. doi: 10.1093/brain/120.1.15. [DOI] [PubMed] [Google Scholar]
  17. Foong J., Rozewicz L., Quaghebeur G., Thompson A. J., Miller D. H., Ron M. A. Neuropsychological deficits in multiple sclerosis after acute relapse. J Neurol Neurosurg Psychiatry. 1998 Apr;64(4):529–532. doi: 10.1136/jnnp.64.4.529. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Frisén L., Hoyt W. F. Insidious atrophy of retinal nerve fibers in multiple sclerosis. Funduscopic identification in patients with and without visual complaints. Arch Ophthalmol. 1974 Aug;92(2):91–97. doi: 10.1001/archopht.1974.01010010097001. [DOI] [PubMed] [Google Scholar]
  19. Grossman R. I., Gonzalez-Scarano F., Atlas S. W., Galetta S., Silberberg D. H. Multiple sclerosis: gadolinium enhancement in MR imaging. Radiology. 1986 Dec;161(3):721–725. doi: 10.1148/radiology.161.3.3786722. [DOI] [PubMed] [Google Scholar]
  20. Halliday A. M., McDonald W. I., Mushin J. Delayed pattern-evoked responses in optic neuritis in relation to visual acuity. Trans Ophthalmol Soc U K. 1973;93(0):315–324. [PubMed] [Google Scholar]
  21. Halliday A. M., McDonald W. I., Mushin J. Delayed visual evoked response in optic neuritis. Lancet. 1972 May 6;1(7758):982–985. doi: 10.1016/s0140-6736(72)91155-5. [DOI] [PubMed] [Google Scholar]
  22. Hohol M. J., Guttmann C. R., Orav J., Mackin G. A., Kikinis R., Khoury S. J., Jolesz F. A., Weiner H. L. Serial neuropsychological assessment and magnetic resonance imaging analysis in multiple sclerosis. Arch Neurol. 1997 Aug;54(8):1018–1025. doi: 10.1001/archneur.1997.00550200074013. [DOI] [PubMed] [Google Scholar]
  23. Hyde T. M., Ziegler J. C., Weinberger D. R. Psychiatric disturbances in metachromatic leukodystrophy. Insights into the neurobiology of psychosis. Arch Neurol. 1992 Apr;49(4):401–406. doi: 10.1001/archneur.1992.00530280095028. [DOI] [PubMed] [Google Scholar]
  24. Katz D., Taubenberger J. K., Cannella B., McFarlin D. E., Raine C. S., McFarland H. F. Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis. Ann Neurol. 1993 Nov;34(5):661–669. doi: 10.1002/ana.410340507. [DOI] [PubMed] [Google Scholar]
  25. Kujala P., Portin R., Ruutiainen J. Language functions in incipient cognitive decline in multiple sclerosis. J Neurol Sci. 1996 Sep 15;141(1-2):79–86. doi: 10.1016/0022-510x(96)00146-3. [DOI] [PubMed] [Google Scholar]
  26. Kujala P., Portin R., Ruutiainen J. The progress of cognitive decline in multiple sclerosis. A controlled 3-year follow-up. Brain. 1997 Feb;120(Pt 2):289–297. doi: 10.1093/brain/120.2.289. [DOI] [PubMed] [Google Scholar]
  27. Lightman S., McDonald W. I., Bird A. C., Francis D. A., Hoskins A., Batchelor J. R., Halliday A. M. Retinal venous sheathing in optic neuritis. Its significance for the pathogenesis of multiple sclerosis. Brain. 1987 Apr;110(Pt 2):405–414. doi: 10.1093/brain/110.2.405. [DOI] [PubMed] [Google Scholar]
  28. Litvan I., Grafman J., Vendrell P., Martinez J. M., Junqué C., Vendrell J. M., Barraquer-Bordas J. L. Multiple memory deficits in patients with multiple sclerosis. Exploring the working memory system. Arch Neurol. 1988 Jun;45(6):607–610. doi: 10.1001/archneur.1988.00520300025012. [DOI] [PubMed] [Google Scholar]
  29. Logsdail S. J., Callanan M. M., Ron M. A. Psychiatric morbidity in patients with clinically isolated lesions of the type seen in multiple sclerosis: a clinical and MRI study. Psychol Med. 1988 May;18(2):355–364. doi: 10.1017/s003329170000790x. [DOI] [PubMed] [Google Scholar]
  30. Lyoo I. K., Seol H. Y., Byun H. S., Renshaw P. F. Unsuspected multiple sclerosis in patients with psychiatric disorders: a magnetic resonance imaging study. J Neuropsychiatry Clin Neurosci. 1996 Winter;8(1):54–59. doi: 10.1176/jnp.8.1.54. [DOI] [PubMed] [Google Scholar]
  31. MCDONALD W. I. THE EFFECTS OF EXPERIMENTAL DEMYELINATION ON CONDUCTION IN PERIPHERAL NERVE: A HISTOLOGICAL AND ELECTROPHYSIOLOGICAL STUDY. II. ELECTROPHYSIOLOGICAL OBSERVATIONS. Brain. 1963 Sep;86:501–524. doi: 10.1093/brain/86.3.501. [DOI] [PubMed] [Google Scholar]
  32. McDonald W. I., Sears T. A. The effects of experimental demyelination on conduction in the central nervous system. Brain. 1970;93(3):583–598. doi: 10.1093/brain/93.3.583. [DOI] [PubMed] [Google Scholar]
  33. Moulin D., Paty D. W., Ebers G. C. The predictive value of cerebrospinal fluid electrophoresis in 'possible' multiple sclerosis. Brain. 1983 Dec;106(Pt 4):809–816. doi: 10.1093/brain/106.4.809. [DOI] [PubMed] [Google Scholar]
  34. O'Riordan J. I., Thompson A. J., Kingsley D. P., MacManus D. G., Kendall B. E., Rudge P., McDonald W. I., Miller D. H. The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10-year follow-up. Brain. 1998 Mar;121(Pt 3):495–503. doi: 10.1093/brain/121.3.495. [DOI] [PubMed] [Google Scholar]
  35. Ormerod I. E., Miller D. H., McDonald W. I., du Boulay E. P., Rudge P., Kendall B. E., Moseley I. F., Johnson G., Tofts P. S., Halliday A. M. The role of NMR imaging in the assessment of multiple sclerosis and isolated neurological lesions. A quantitative study. Brain. 1987 Dec;110(Pt 6):1579–1616. doi: 10.1093/brain/110.6.1579. [DOI] [PubMed] [Google Scholar]
  36. Patti F., Di Stefano M., De Pascalis D., Ciancio M. R., De Bernardis E., Nicoletti F., Reggio A. May there exist specific MRI findings predictive of dementia in multiple sclerosis patients? Funct Neurol. 1995 Mar-Apr;10(2):83–90. [PubMed] [Google Scholar]
  37. Paulesu E., Perani D., Fazio F., Comi G., Pozzilli C., Martinelli V., Filippi M., Bettinardi V., Sirabian G., Passafiume D. Functional basis of memory impairment in multiple sclerosis: a[18F]FDG PET study. Neuroimage. 1996 Oct;4(2):87–96. doi: 10.1006/nimg.1996.0032. [DOI] [PubMed] [Google Scholar]
  38. Pelosi L., Geesken J. M., Holly M., Hayward M., Blumhardt L. D. Working memory impairment in early multiple sclerosis. Evidence from an event-related potential study of patients with clinically isolated myelopathy. Brain. 1997 Nov;120(Pt 11):2039–2058. doi: 10.1093/brain/120.11.2039. [DOI] [PubMed] [Google Scholar]
  39. Pine D. S., Douglas C. J., Charles E., Davies M., Kahn D. Patients with multiple sclerosis presenting to psychiatric hospitals. J Clin Psychiatry. 1995 Jul;56(7):297–308. [PubMed] [Google Scholar]
  40. Poser C. M., Paty D. W., Scheinberg L., McDonald W. I., Davis F. A., Ebers G. C., Johnson K. P., Sibley W. A., Silberberg D. H., Tourtellotte W. W. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol. 1983 Mar;13(3):227–231. doi: 10.1002/ana.410130302. [DOI] [PubMed] [Google Scholar]
  41. Pujol J., Bello J., Deus J., Martí-Vilalta J. L., Capdevila A. Lesions in the left arcuate fasciculus region and depressive symptoms in multiple sclerosis. Neurology. 1997 Oct;49(4):1105–1110. doi: 10.1212/wnl.49.4.1105. [DOI] [PubMed] [Google Scholar]
  42. Rao S. M., Leo G. J., Bernardin L., Unverzagt F. Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction. Neurology. 1991 May;41(5):685–691. doi: 10.1212/wnl.41.5.685. [DOI] [PubMed] [Google Scholar]
  43. Rao S. M., Leo G. J., Ellington L., Nauertz T., Bernardin L., Unverzagt F. Cognitive dysfunction in multiple sclerosis. II. Impact on employment and social functioning. Neurology. 1991 May;41(5):692–696. doi: 10.1212/wnl.41.5.692. [DOI] [PubMed] [Google Scholar]
  44. Reischies F. M., Baum K., Bräu H., Hedde J. P., Schwindt G. Cerebral magnetic resonance imaging findings in multiple sclerosis. Relation to disturbance of affect, drive, and cognition. Arch Neurol. 1988 Oct;45(10):1114–1116. doi: 10.1001/archneur.1988.00520340068014. [DOI] [PubMed] [Google Scholar]
  45. Revesz T., Kidd D., Thompson A. J., Barnard R. O., McDonald W. I. A comparison of the pathology of primary and secondary progressive multiple sclerosis. Brain. 1994 Aug;117(Pt 4):759–765. doi: 10.1093/brain/117.4.759. [DOI] [PubMed] [Google Scholar]
  46. Ron M. A., Callanan M. M., Warrington E. K. Cognitive abnormalities in multiple sclerosis: a psychometric and MRI study. Psychol Med. 1991 Feb;21(1):59–68. doi: 10.1017/s0033291700014653. [DOI] [PubMed] [Google Scholar]
  47. Ron M. A., Logsdail S. J. Psychiatric morbidity in multiple sclerosis: a clinical and MRI study. Psychol Med. 1989 Nov;19(4):887–895. doi: 10.1017/s0033291700005602. [DOI] [PubMed] [Google Scholar]
  48. Rovaris M., Filippi M., Falautano M., Minicucci L., Rocca M. A., Martinelli V., Comi G. Relation between MR abnormalities and patterns of cognitive impairment in multiple sclerosis. Neurology. 1998 Jun;50(6):1601–1608. doi: 10.1212/wnl.50.6.1601. [DOI] [PubMed] [Google Scholar]
  49. Rushton D. Use of the Pulfrich pendulum for detecting abnormal delay in the visual pathway in multiple sclerosis. Brain. 1975 Jun;98(2):283–296. doi: 10.1093/brain/98.2.283. [DOI] [PubMed] [Google Scholar]
  50. Sabatini U., Pozzilli C., Pantano P., Koudriavtseva T., Padovani A., Millefiorini E., Di Biasi C., Gualdi G. F., Salvetti M., Lenzi G. L. Involvement of the limbic system in multiple sclerosis patients with depressive disorders. Biol Psychiatry. 1996 Jun 1;39(11):970–975. doi: 10.1016/0006-3223(95)00291-x. [DOI] [PubMed] [Google Scholar]
  51. Sadovnick A. D., Eisen K., Ebers G. C., Paty D. W. Cause of death in patients attending multiple sclerosis clinics. Neurology. 1991 Aug;41(8):1193–1196. doi: 10.1212/wnl.41.8.1193. [DOI] [PubMed] [Google Scholar]
  52. Schiffer R. B., Wineman N. M., Weitkamp L. R. Association between bipolar affective disorder and multiple sclerosis. Am J Psychiatry. 1986 Jan;143(1):94–95. doi: 10.1176/ajp.143.1.94. [DOI] [PubMed] [Google Scholar]
  53. Shibasaki H., McDonald W. I., Kuroiwa Y. Racial modification of clinical picture of multiple sclerosis: comparison between British and Japanese patients. J Neurol Sci. 1981 Feb;49(2):253–271. doi: 10.1016/0022-510x(81)90083-6. [DOI] [PubMed] [Google Scholar]
  54. Sibley W. A., Bamford C. R., Clark K. Clinical viral infections and multiple sclerosis. Lancet. 1985 Jun 8;1(8441):1313–1315. doi: 10.1016/S0140-6736(85)92801-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Skegg K., Corwin P. A., Skegg D. C. How often is multiple sclerosis mistaken for a psychiatric disorder? Psychol Med. 1988 Aug;18(3):733–736. doi: 10.1017/s0033291700008436. [DOI] [PubMed] [Google Scholar]
  56. Thompson A. J., Kermode A. G., Wicks D., MacManus D. G., Kendall B. E., Kingsley D. P., McDonald W. I. Major differences in the dynamics of primary and secondary progressive multiple sclerosis. Ann Neurol. 1991 Jan;29(1):53–62. doi: 10.1002/ana.410290111. [DOI] [PubMed] [Google Scholar]
  57. Thompson A. J., Polman C. H., Miller D. H., McDonald W. I., Brochet B., Filippi M Montalban X., De Sá J. Primary progressive multiple sclerosis. Brain. 1997 Jun;120(Pt 6):1085–1096. doi: 10.1093/brain/120.6.1085. [DOI] [PubMed] [Google Scholar]
  58. Weinshenker B. G., Bass B., Rice G. P., Noseworthy J., Carriere W., Baskerville J., Ebers G. C. The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability. Brain. 1989 Feb;112(Pt 1):133–146. doi: 10.1093/brain/112.1.133. [DOI] [PubMed] [Google Scholar]

Articles from Philosophical Transactions of the Royal Society B: Biological Sciences are provided here courtesy of The Royal Society

RESOURCES